Novo Nordisk in the United StatesAt Novo Nordisk, we believe in change. We seek opportunities to

contribute to healthier communities and better lives for all people.

And we drive change by listening, learning and improving.

For 95 years, we have been driving change to defeat diabetes,

inspired by the courage of the people we support. Our heritage in

diabetes has given us the experience and capability to help defeat

other serious chronic conditions: hemophilia, growth disorders and

obesity.

Every change in the right direction counts, from innovations in

medicines and embarking on new partnerships to the everyday efforts

and choices that people living with a chronic condition make as they

strive to live the life they want.

We work for a future where lives are not limited. To achieve this, we

take the lead and continuously challenge the status quo by looking at

change from new perspectives.

NEARLY 6,000 EMPLOYEES ACROSS U.S. LOCATIONS

EST.

ESTABLISHED IN 1923, COPENHAGEN, DENMARK

FAST FACTS

U.S. Headquarters in Plainsboro, NJ, with locations in five states

Approximately 560 people working in R&D in the U.S.

Working within diabetes, hemophilia, growth disorders and obesity

$8.5 BILLION TOTAL U.S. SALES IN 2017

Approximately 250,000 shareholders

17 medicines marketed across therapeutic areas

Patient assistance program maintained for eligible patients who may be having a challenge affording their medicines

$

THE TRIPLE BOTTOM LINE

To ensure that we can be in business for the next generations, we must always act responsibly, considering the impact of our business on people, communities and the environment when we make decisions and always keeping in mind the best interests of the patients we serve.

We call this approach the Triple Bottom Line.

U.S. Headquarters Location 800 Scudders Mill RdPlainsboro Township, NJ 08536

Anders KristenssonType 2 Diabetes

WEST LEBANON, NH PLAINSBORO, NJ CLAYTON, NC

SEATTLE, WA INDIANAPOLIS, IN

Socially responsible

Environmentallyresponsible

Financially responsible

Mary EdwardsObesity

Actions that drive changeMaking life-saving medicine is a significant responsibility — millions of people depend on us. However, to help defeat serious chronic

conditions, we need to do more. Below are some of our activities and programs in the U.S.

Novo Nordisk Inc., 800 Scudders Mill Rd., Plainsboro, NJ 08536 U.S.A.

Novo Nordisk is a registered trademark of Novo Nordisk A/S. ©2018 Novo Nordisk US18CORP00020 Last Updated: May 2018

About Novo Nordisk in the U.S.:

Novo Nordisk, a global healthcare company, has been committed to discovering and developing innovative medicines to help people living with diabetes lead longer, healthier lives for 95 years. This heritage has given us experience and capabilities that also enable us to help people defeat other serious diseases, including obesity, hemophilia and growth disorders. We remain steadfast in our conviction that the formula for success is to stay focused, think long term and do business in a financially, socially and environmentally responsible way. With U.S. headquarters in New Jersey and production and research facilities in four states, Novo Nordisk employs nearly 6,000 people throughout the country. For more information, visit novonordisk.us, Facebook and Twitter.

For more information about Novo Nordisk’s U.S. headquarters, visit: novonordisk.us

FOLLOW US

facebook.com/novonordiskus linkedin.com/company/novo-nordisk twitter.com/novonordiskus

Since Novo Nordisk was founded 95 years ago, we have been

changing diabetes. Our key contribution is to discover and develop

better medicines. However, to defeat this serious disease, we need to

do more to address the unmet needs of people with diabetes.

it deserves in order to improve the lives of people

affected by diabetes and prediabetes, today and in

the future. ACT for Diabetes is an advocacy tool to

help people do just that.

Treat and Reduce Obesity Act CoalitionWith the goal of expanding available obesity

treatment options under Medicare, leading patient

and healthcare professional groups came together to

form the Treat and Reduce Obesity Act Coalition.

Novo Nordisk is pleased to be a member.

Obesity Care Advocacy NetworkCreated to elevate obesity on the national agenda, the Obesity Care Advocacy Network unites and aligns obesity stakeholders and the community around obesity-related education, policy and legislative efforts. We are proud to be an original member of this network.

Ask.Screen.Know.Ask.Screen.Know. is a national program dedicated to educating Americans about their risk for diabetes and encouraging diabetes screening.

Cities Changing DiabetesCities Changing Diabetes, a global program sponsored by Novo Nordisk, is a private/public partnership that works to improve the lives of people living with or at high risk for developing diabetes in cities throughout the world. In Houston, a coalition of medical and public health institutions, faith-based organizations, employers, insurers and non-profits developed and is implementing unique community-based initiatives to improve diabetes care, outreach and prevention.

Cornerstones4Care®

Cornerstones4Care® delivers personalized support based on a person’s individual needs so that they feel more empowered to manage their diabetes. Healthy eating, being active, diabetes medicine and tracking — patients manage what’s most important to them, all in one place. It includes topics that can be put into practice, interactive tracking tools and other helpful resources like live Certified Diabetes Educator (CDE) phone calls with a Diabetes Health Coach.

Truth About WeightTM

To help patients prepare for a productive conversation with their healthcare provider, TruthAboutWeight.com provides information around the science behind weight loss and provides tools to help assess weight management history, motivations and triggers. This educational resource was developed for patients by Novo Nordisk.

Novo Nordisk WORKSTM

Developed by Novo Nordisk to help employers understand the value of chronic weight management in the workplace, Novo Nordisk WORKS™ provides resources to helporganizations improve employee health and decrease health-related costs.

World Diabetes Day, World Hemophilia Day and National Obesity Care WeekEvery year on World Diabetes Day on November 14 and World Hemophilia Day on April 17, Novo Nordisk, together with international and local organizations, unites communities to raise awareness of these chronic conditions. We are

proud to be the founding sponsor of National Obesity Care Week (last week of Oct./first week of Nov.), an annual initiative aiming to create a society that understands, respects and accepts the complexities of obesity and values science-based care.

Grants and Corporate GivingWe are committed to making a difference by supporting scientific and humanitarian causes that positively impact lives. For example, as part of our commitment to the Triple Bottom Line, Novo Nordisk launched Ready, Set, Healthy!, a grant program designed to reduce the rate of type 2 diabetes by increasing knowledge and access to: healthy, affordable foods; physical activity; and providing students, parents and caregivers the tools to make healthy lifestyle choices.

Diabetes Advocacy AllianceTM (DAA)Novo Nordisk is a founding member of the DAA, a coalition representing patient, professional and trade associations; other nonprofit organizations; and corporations — all united in the desire to change the way diabetes is viewed and treated in America. The vision of the DAA is to influence change in the U.S. healthcare system to improve diabetes prevention, detection and care and to speed the development of pathways to cures for diabetes.

ACT for DiabetesACT for Diabetes stands for “Achieving Change

Together for Diabetes.” Novo Nordisk believes

advocacy is essential to achieving policy change and

legislation that will help give diabetes the attention

For more than three decades, Novo Nordisk has been committed

to changing hemophilia. In addition to discovering and developing

effective medicines, we work with our community partners to

improve the lives of people with hemophilia.

Zihao LiHemophilia

Linda TaylorHemophilia

Flinn SargeantGrowth Hormone

Deficiency